Australia markets closed

uniQure N.V. (QURE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
19.11-0.43 (-2.20%)
At close: 04:00PM EDT
18.60 -0.51 (-2.67%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close19.54
Open19.74
Bid18.50 x 800
Ask19.38 x 1000
Day's range18.18 - 19.95
52-week range12.52 - 38.80
Volume1,618,885
Avg. volume648,185
Market cap891.436M
Beta (5Y monthly)1.12
PE ratio (TTM)2.77
EPS (TTM)6.89
Earnings date25 July 2022 - 29 July 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est52.35
  • Zacks

    uniQure (QURE) Up on Safety Data From Huntington's Disease Study

    uniQure (QURE) posts safety and biomarker data from the 10 patients enrolled in the lower-dose cohort of its ongoing phase I/II study evaluating AMT-130 for treating Huntington's disease.

  • GlobeNewswire

    uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease

    Bar Chart Bar Chart ~ Treatment generally well-tolerated with no significant safety issues related to AMT-130 in treated patients through one year of follow-up ~ ~ A mean reduction of 53.8% of mutant HTT (mHTT) observed in cerebral spinal fluid (CSF) at 12 months in evaluable patients treated with AMT-130 ~ ~ Neurofilament Light Chain (NfL) in CSF near baseline at 12 months in patients treated with AMT-130 ~ ~ Biomarker and clinical data including 24-month follow-up in the low-dose U.S. cohort a

  • GlobeNewswire

    CORRECTION -- uniQure Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    LEXINGTON, Mass. and AMSTERDAM, the Netherlands, June 22, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by uniQure N.V. (NASDAQ: QURE), please note that all the numbers have been updated. The corrected release follows: uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the Company granted equity awards to 22 employees as a material inducement to commencing